152 related articles for article (PubMed ID: 10449671)
1. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study.
Ho WK; Wei WI; Kwong DL; Sham JS; Tai PT; Yuen AP; Au DK
Head Neck; 1999 Sep; 21(6):547-53. PubMed ID: 10449671
[TBL] [Abstract][Full Text] [Related]
2. A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy.
Wang LF; Kuo WR; Ho KY; Lee KW; Lin CS
Otol Neurotol; 2004 Mar; 25(2):168-73. PubMed ID: 15021778
[TBL] [Abstract][Full Text] [Related]
3. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients.
Petsuksiri J; Sermsree A; Thephamongkhol K; Keskool P; Thongyai K; Chansilpa Y; Pattaranutaporn P
Radiat Oncol; 2011 Feb; 6():19. PubMed ID: 21333025
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma.
Li JJ; Guo YK; Tang QL; Li SS; Zhang XL; Wu PA; Yang XM
J Laryngol Otol; 2010 Jan; 124(1):32-6. PubMed ID: 19840426
[TBL] [Abstract][Full Text] [Related]
5. Hearing loss in patients with nasopharyngeal carcinoma after chemotherapy and radiation.
Wang LF; Kuo WR; Ho KY; Lee KW; Lin CS
Kaohsiung J Med Sci; 2003 Apr; 19(4):163-9. PubMed ID: 12795345
[TBL] [Abstract][Full Text] [Related]
6. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.
Low WK; Toh ST; Wee J; Fook-Chong SM; Wang DY
J Clin Oncol; 2006 Apr; 24(12):1904-9. PubMed ID: 16622266
[TBL] [Abstract][Full Text] [Related]
7. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
[TBL] [Abstract][Full Text] [Related]
8. Hearing Assessment after Treatment of Nasopharyngeal Carcinoma with CRT and IMRT Techniques.
Hwang CF; Fang FM; Zhuo MY; Yang CH; Yang LN; Hsieh HS
Biomed Res Int; 2015; 2015():769806. PubMed ID: 26351638
[TBL] [Abstract][Full Text] [Related]
9. [Damage to inner ear function caused by the effect of ionizing rays].
Strohm M; Ahlemann LM; Böhringer WK
HNO; 1985 Jan; 33(1):26-9. PubMed ID: 3972645
[TBL] [Abstract][Full Text] [Related]
10. Incidence of long-term ipsilateral and contralateral ototoxicity following radiotherapy for nasopharyngeal carcinoma.
Wakisaka H; Yamada H; Motoyoshi K; Ugumori T; Takahashi H; Hyodo M
Auris Nasus Larynx; 2011 Feb; 38(1):95-100. PubMed ID: 20541337
[TBL] [Abstract][Full Text] [Related]
11. Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.
Oh YT; Kim CH; Choi JH; Kang SH; Chun M
Radiother Oncol; 2004 Jul; 72(1):79-82. PubMed ID: 15236878
[TBL] [Abstract][Full Text] [Related]
12. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
Kwong DL; Wei WI; Sham JS; Ho WK; Yuen PW; Chua DT; Au DK; Wu PM; Choy DT
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):281-9. PubMed ID: 8892450
[TBL] [Abstract][Full Text] [Related]
13. Methylprednisolone use during radiotherapy extenuates hearing loss in patients with nasopharyngeal carcinoma.
Chen J; Zhao Y; Zhou X; Tan L; Ou Z; Yu Y; Wang Y
Laryngoscope; 2016 Jan; 126(1):100-3. PubMed ID: 26309227
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
[TBL] [Abstract][Full Text] [Related]
15. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analyses of sudden sensorineural hearing loss in 14 nasopharyngeal carcinomas following radiotherapy].
Chen P; Tang AZ; Zhang Z; Yin SH; Cai HW; Fang Q; He GY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):705-8. PubMed ID: 22177034
[TBL] [Abstract][Full Text] [Related]
18. Long-term hearing results and otological complications of nasopharyngeal carcinoma patients: comparison between treatment with conventional two-dimensional radiotherapy and intensity-modulated radiotherapy.
Tsang RK; Kwong DL; Ho AC; To VS; Ho WK; Wei WI
ORL J Otorhinolaryngol Relat Spec; 2012; 74(4):228-33. PubMed ID: 22907195
[TBL] [Abstract][Full Text] [Related]
19. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
Yip PL; Mok KCJ; Ho HS; Lee WYV; Wong ACL; Lau CT; Wong FCS; Yeung KW; Lee SF
Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e160-e167. PubMed ID: 34772581
[TBL] [Abstract][Full Text] [Related]
20. Long-term hearing status after radiotherapy for nasopharyngeal carcinoma.
Low WK; Fong KW
Auris Nasus Larynx; 1998 Jan; 25(1):21-4. PubMed ID: 9512790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
